A Phase 1/2 , Open-Label Safety Pharmacokinetic and Efficacy Stydy of TAS4464 in Patients with Multiple Myeloma or Lymphoma - Regional Cancer Care Associates LLC

Clinical Trials

A Phase 1/2 , Open-Label Safety Pharmacokinetic and Efficacy Stydy of TAS4464 in Patients with Multiple Myeloma or Lymphoma

Type of Cancer
Lymphoma
Multiple Myeloma
Locations
Bethesda
Sponsor
Protocol Number
TAS4464-101
Cancer Diagnosis
To Learn More Call
201-510-0910